Sichuan Elixir Pharmaceutical Co., Ltd.

Focus on Natural Origin, High Potency, Cytotoxic, Niche APIs, set up R&D and production platform for new salt and crystal form, cooperate deeply with clients for IND, NDA, ANDA, 505 (b)(2) or P-IV challenge. Explore the potential of macromolecular APIs, set up R&D and production platform for Glycans and Polypeptide. Specialize in XDC drugs field, commit to platform building for the innovative research and production on Payload and Linker. Globalized registration platform, professional team, and international cGMP system. API CMO / CDMO service with global registration (FDA, EDQM, PMDA, NMPA). Strategy: FDF + APIs.（Sales,Technical Dossier Transfer,License in&out）.